Dáil Éireann

Total Page:16

File Type:pdf, Size:1020Kb

Dáil Éireann DÁIL ÉIREANN AN COMHCHOISTE UM SHLÁINTE JOINT COMMITTEE ON HEALTH Dé Céadaoin, 23 Meitheamh 2021 Wednesday, 23 June 2021 Tháinig an Comhchoiste le chéile ag 9.30 a.m. The Joint Committee met at 9.30 a.m. Comhaltaí a bhí i láthair/Members present: Teachtaí Dála/Deputies Seanadóirí/Senators Colm Burke, Martin Conway, Cathal Crowe, Annie Hoey, David Cullinane, Seán Kyne. Bernard J. Durkan, Gino Kenny, John Lahart. Teachta/Deputy Seán Crowe sa Chathaoir/in the Chair. 1 JH Business of Joint Committee Chairman: Apologies have been received from Deputy Hourigan and Senator Black. Be- fore we commence our formal proceedings, we need to agree the draft minutes for last week’s meeting of 16 June, which have been circulated. Are they agreed? Agreed. Update on the Cyberattack, Covid-19 Vaccination Roll-out and Covid-19 Restrictions in Maternity Hospitals: Health Service Executive Chairman: I welcome the witnesses to our meeting this morning. They will provide an update on the recent cyberattack, the Covid-19 vaccination roll-out and the public health re- strictions in maternity hospitals. From the HSE, we have Mr. Paul Reid, chief executive officer; Ms Anne O’Connor, chief operations officer, Dr. Colm Henry, chief clinical officer; Mr. Fran Thompson, chief information officer; and Mr. Damien McCallion, national lead of the Covid-19 vaccination programme. Before we hear their opening statements, I need to point out to our witnesses that there is uncertainty as to whether parliamentary privilege will apply to evidence that is given from a location outside the parliamentary precincts of Leinster House. Therefore, if they are directed by me to cease giving evidence on a particular matter, they must respect that direction. I believe the witnesses are within the precincts of Leinster House today, so it does not really apply. I call Mr. Reid to make his opening remarks. He is most welcome. Mr. Paul Reid: There is significant interference on the headset in the room in which I am located. The technical team is trying to resolve the issue. Chairman: Do you want us to wait until the issue has been resolved before commencing? Mr. Paul Reid: No. The technical team will work on it in the background. There may be some background noises. Apologies for that. I thank the Chairman and members for the invitation to meet with the committee to provide an update on the cyberattack on the HSE IT systems, the roll-out of the Covid-19 vaccination programme, and visiting at maternity hospitals. I am joined today by my colleagues ,Ms Anne O’Connor, chief operations officer, Dr. Colm Henry, chief clinical officer, Mr. Fran Thompson, chief information officer, and Mr. Damien McCallion, national lead, Covid-19 vaccination pro- gramme. I thank the committee members for their support following the cyberattack and for their patience and forbearance over recent weeks. We know they have been wanting to convene a session with the HSE for some time. I also thank the public for their support and to say to them I regret the inconvenience and worry experienced by many arising from the deplorable incident. Chairman: Apologies, Mr. Reid, but the sound is dropping out. We will suspend for a few minutes. I assume the witnesses are getting the same feedback. Yes. It is not just the malware. We have had similar difficulties with the IT system in Leinster House. It has been going on for weeks now. We will resume at 9.40 a.m., when it is hoped the issue will have been resolved. Sitting suspended at 9.35 a.m. and resumed at 9.46 a.m. 2 23 JUNE 2021 Chairman: I apologise to those watching the meeting at home and to our witnesses today. Mr. Paul Reid: On 14 May a human-operated “Conti” ransomware attack was detected on our network. It severely disabled a number of systems and necessitated the complete shut- down of the HSE’s network. We have been working to recover systems ever since. The HSE response contains four stages. First, the containment phase, which is now completed. Second, the inform phase, which is also complete, but the task is ongoing. Daily and weekly briefings are being provided to multiple stakeholders. Third, the assess phase, which involves the res- toration of services and eradication of ransomware from the network. That phase is continu- ing. Finally, the remedy phase, which involves strengthening our network against future cyber threats. That phase is continuing. The restoration process and the accompanying due diligence exercise is necessarily taking some time. Although we can effectively decrypt data, that is only one element of it. The mal- ware must also be eradicated. Decryption takes much longer than the original encryption, and eradication involves additional tasks to ensure that the perpetrators have no access route back into our systems. We have worked with specialist cybersecurity firms and our application ven- dors to develop solutions to improve the efficiency of the decryption and eradication process, and it is showing dividends. So far, 75% of our server estate has been decrypted and 70% of our end-user devices are now available. While the architecture of our network dictates a certain initial sequence to the restoration of services, the majority of our sequencing decisions are clinically informed. We are focusing our efforts on restoring the systems most critical to patient care in the first instance. From a techni- cal standpoint, many systems are now operational again, but restoring interoperability between systems and sites is ongoing. That continues to impact on service delivery. Characteristically, our staff across the country have worked extremely hard to keep services going in the face of the enormous challenges presented by the cyberattack and ensuing shutdown. They are doing this at a time when our health system is experiencing very high demand for services. I want to particularly thank staff for their hard work and commitment to the delivery of services to the public at this time. Our IT staff, supported by the Defence Forces and contracted IT experts, have maintained a relentless schedule. This continues seven days a week. There is no underestimating the damage that this cyberattack has caused. There are finan- cial costs, certainly, but there will, unfortunately, also be human costs. I assure members and the public that we are doing everything possible to restore the systems. I must also caution that it will likely take months before systems are fully restored. Accordingly, I must ask the public for continued forbearance and understanding. I am pleased to say that the Covid-19 vaccination programme is making really good prog- ress. We administered 340,000 vaccinations last week and GPs have administered close to 1.5 million vaccines. Our other vaccination channels, namely, community-based vaccination teams, acute hospitals, ambulance and community pharmacies, are also functioning very ef- fectively indeed. We have 39 vaccination centres in place. Over 3.7 million vaccines have been administered. Over 2.3 million people have now received a first dose, or single dose, of the vaccine and over 1.3 million have received a second dose, or single dose. Our key objective in prioritising vac- cine cohorts is to protect the most vulnerable. It is apparent, given the major drop in hospitali- sations and mortality, that we are achieving this. 3 JH It is probably accepted by everyone that the health and well-being of mothers and babies has been at the heart of maternity visit restrictions, which I accept are a significant burden. Hospi- tals must apply infection prevention and control measures in a manner appropriate to the physi- cal infrastructure that they have. We have provided guidance on partner access as I will outline. Maternity services should facilitate a minimum of a 30 minute visit daily. The partner should be facilitated during labour while the woman is in the labour ward. It may not be possible to fa- cilitate women in multi-occupancy antenatal wards before they go to the labour ward. Partners should be facilitated at the anomaly scan and any other visit that may involve communications of emotional significance. Parents should be facilitated in the national neonatal intensive care unit, NICU. Given the improved Covid-19 situation, we recently asked all maternity hospitals and units to review their approach again. This week, the national women and infants health programme is meeting with the clinical leads of the six maternity networks. Subject to infra- structure limitations, I am confident that the least restrictive approach possible will be adopted. Senator Martin Conway: Good morning. I thank the witnesses for the great work that they are doing with the cyberattack, which had not been planned for. The vaccination roll-out programme is going well. I acknowledge the work of Mr. Damien McCallion in leading the vaccination programme. It has gone well. Can Mr. Reid estimate the cost of the cyberattack to date and what it will be in the future? I suspect it might be as much as €500 million. What is the cost for the companies engaged? Did the HSE use a particular country’s expertise with regard to this attack when getting support from other countries? Is any interruption to supply for the vaccination programme envisaged in the next couple of weeks? Will the supply that has been committed to be honoured? What target will the HSE achieve by the end of July? Are difficulties with supply envisaged? Is Mr. Reid confident that the supply lines that have been agreed will be honoured? Mr. Paul Reid: The Senator’s opening remarks are much appreciated and will be passed on to everybody. Regarding the cyberattack and cost, there are a few aspects for now and the fu- ture, as the Senator said.
Recommended publications
  • Appendix 1 – NPHET Membership Details Membership at a Point in Time Reflects the Work Ongoing
    Appendix 1 – NPHET Membership Details Membership at a point in time reflects the work ongoing. Expert advisors and / or other stakeholders may be invited to attend meetings from time to time. Dr Tony Holohan (Chair) Chief Medical Officer, Department of Health (DOH) Prof Colm Bergin Consultant Infectious Diseases, St. James’s Hospital and Professor of Medicine, Trinity College Dublin Mr Paul Bolger Director, Resources Division, DOH Dr Eibhlin Connolly Deputy Chief Medical Officer, DOH Ms Tracey Conroy A/Sec, Acute Hospitals Division, DOH Dr John Cuddihy Interim Director, Health Protection Surveillance Centre (HPSC) Dr Cillian de Gascun Director, National Virus Reference Laboratory (NVRL), UCD, Consultant Virologist Mr Colm Desmond A/Sec, Corporate Legislation, Mental Health, Drugs Policy and Food Safety Division, DOH Dr Lorraine Doherty National Clinical Director for Health Protection, HPSC, HSE Dr Mary Favier President, Irish College of General Practitioners (ICGP) Dr Ronan Glynn Deputy Chief Medical Officer, DOH Mr Fergal Goodman A/Sec, Primary Care Division, DOH Dr Colm Henry Chief Clinical Officer, HSE Dr Kevin Kelleher Asst. National Director, Public Health, HSE Ms Marita Kinsella Director, National Patient Safety Office, DOH Mr David Leach Deputy National Director of Communications, HSE Dr Kathleen Mac Lellan A/Sec, Social Care Division, DOH Dr Jeanette Mc Callion Medical Assessor, Health Products Regulatory Authority (HPRA) Mr Tom McGuinness Asst. National Director, Office of Emergency Planning, HSE Dr Siobhán Ní Bhrian Lead for
    [Show full text]
  • 1 National Public Health Emergency Team – COVID-19 Meeting Note
    National Public Health Emergency Team – COVID-19 Meeting Note – Standing meeting Date and Time Thursday 7th January 2021, (Meeting 71) at 10:00am Location Department of Health, Miesian Plaza, Dublin 2 Chair Dr Tony Holohan, Chief Medical Officer, DOH Dr Ronan Glynn, Deputy Chief Medical Officer, DOH Dr Kevin Kelleher, Assistant National Director, Public Health, HSE Prof Philip Nolan, President, National University of Ireland, Maynooth and Chair of the Irish Epidemiological Modelling Advisory Group (IEMAG) Dr Cillian de Gascun, Laboratory Director, NVRL and Expert Advisory Group (EAG) Chair Dr Máirín Ryan, Deputy Chief Executive and Director of HTA, HIQA Dr John Cuddihy, Interim Director, HSE HPSC Dr Siobhán Ní Bhriain, Lead for Integrated Care, HSE Dr Eibhlín Connolly, Deputy Chief Medical Officer, DOH Dr Mary Favier, Immediate past president of the ICGP, Covid-19 advisor Dr Michael Power, Consultant in Anaesthetics / Intensive Care Medicine, Beaumont Hospital Ms Rachel Kenna, Chief Nursing Officer, DOH Mr Greg Dempsey, Deputy Secretary, Governance and Performance Division, DOH Ms Tracey Conroy, Assistant Secretary, Acute Hospitals Policy Division, DOH Dr Lorraine Doherty, National Clinical Director Health Protection, HSE Members via Dr Colette Bonner, Deputy Chief Medical Officer, DOH videoconference1 Mr Colm Desmond, Assistant Secretary, Corporate Legislation, Mental Health, Drugs Policy and Food Safety Division, DOH Ms Yvonne O’Neill, National Director, Community Operations, HSE Mr Phelim Quinn, Chief Executive Officer, HIQA Dr Siobhán
    [Show full text]
  • Irish Universities Help F Ight the Covid-19 Pandemic
    IRISH UNIVERSITIES HELP FIGHT THE COVID-19 PANDEMIC www.iua.ie @IUAofficial Irish Universities help fight the COVID-19 Pandemic Doctors Samer Arnous, Tony Moloney and Nick Barrett at University Hospital Limerick, testing University of Limerick produced visors and shield box. Exec Summary The COVID-19 pandemic has created unprecedented societal challenges. The Irish university sector has maintained ‘business as usual’ to the greatest extent possible by a rapid transition to remote learning and assessment. Meanwhile, the sector galvanised into immediate action, contributing to the national emergency response in every way possible as the pandemic developed. Our universities and their staff and students have, and are, making a hugely valuable contribution to the national efforts to fight the COVID-19 pandemic. We have captured key highlights in this publication. A more comprehensive schedule can be found at https://www.iua.ie/covid-19/universities-help- fight-the-pandemic/ Irish Universities help fight the COVID-19 Pandemic 3 Here are the key highlights of university efforts: Page 07 1 Page 11 2 COVID-19 testing Expert advice with staff and contact tracing: and students on the frontline: Highly skilled diagnostic laboratory staff from our Expert advice has been the hallmark of dealing with universities have been readily mobilised to undertake the COVID-19 crisis. Leading academics from across laboratory processing of samples and to take swabs the university sector have been on hand to guide and from patients at testing hubs. support the response: • Our researchers rose to the challenge of the • University leaders such asMaynooth University scarcity of testing reagents with our labs rallying to President, Philip Nolan and University College produce lysis buffer, viral transport medium and Dublin’s Dr Cillian de Gascun, have headed up key other essential solutions.
    [Show full text]
  • High Level Task Force on COVID-19 Vaccination 21St December 2020
    High Level Task Force on COVID-19 Vaccination 21st December 2020 Meeting Updates, decisions and actions from meeting High Level Taskforce on COVID-19 Vaccination | 21st December 2020 Meeting High Level Task Force on COVID-19 Vaccination Monday 21st December 2020 14:00 Updates, decisions and actions arising from meeting 1. Attendees A. Members in attendance B. Additional attendees in support Prof. Brian MacCraith, Task Force Chair i. Task Force Secretariat Dr Tony Holohan, Chief Medical Officer, DOH Kate Waterhouse, Task Force Secretariat Fergal Goodman, Assistant Secretary, Health ii. In Attendance Protection Division, DOH Liz Canavan, Chair, Senior Officials Group on Dr Lorraine Doherty, Clinical Director Health COVID-19 Protection, HSE Paul Reid, Chief Executive Officer, HSE Sean Bresnan, National Director of Procurement, HSE Dr Colm Henry, Chief Clinical Officer, HSE Gerry O’Brien, Director, Health Protection, DOH Paul Quinn, Government CPO and CEO, OGP Deirdre Watters, Head of Communications, DOH Barry Lowry, Chief Information Officer, OGCIO Lucy Jessop, SRO Director, National Immunisation Office, HSE Dermot Mulligan, Assistant Secretary, Innovation David Walsh, SRO WS4 - Vaccine Process & and Investment Division, DETE Workforce Derek McCormack, Expert on Cold Chain Logistics John Cuddihy, SRO WS5 - Surveillance, Monitoring and Reporting Dalton Philips, Chief Executive Officer, DAA Fran Thompson, SRO WS6 - Enabling Technology & Information Lorraine Nolan, Chief Executive, Health Products Michael Lohan, IDA Regulatory Authority (HPRA) Rachel Kenna, Chief Nursing Officer, DOH iii. Programme support Prof Karina Butler, Chair, National Immunisation Michael McDaid (PWC), Programme Office Advisory Committee (NIAC) Derek Tierney, Programme Director Yvonne Mowlds (PWC), Programme Office 2 High Level Taskforce on COVID-19 Vaccination | 21st December 2020 Meeting 2.
    [Show full text]
  • Dr Tony Holohan Chief Medical Officer Chair of the National Public Health Emergency Team Department of Health Miesian Plaza Dublin 2 Vía Email: [email protected] C.C
    Morrison Chambers 32 Nassau Street Dublin 2 D02 YE06 01 679 3188 Dr Tony Holohan Chief Medical Officer Chair of the National Public Health Emergency Team Department of Health Miesian Plaza Dublin 2 Vía email: [email protected] c.c. Professor Martin Cormican; HSE, Dr Ronan Glynn, Department of Health Vía email: [email protected], [email protected] Wednesday, 26 March 2021 Dear Dr Holohan, Firstly, let me extend my condolences to you on the death of your wife last month. I hope you are doing well and managing during these extraordinary times. We write concerning the restrictions imposed at this time on funerals and the rituals that surround dying in Ireland. Bereavement is intrinsically lonely, COVID-19 restrictions have made it more isolating. It has reduced people’s general social outlets, working patterns and natural support networks. The current restrictions of allowing only 10 people attend any aspect of a funeral is causing additional stress, anxiety and heartache to many families. We see the current restrictions as being overly harsh and should be revisited as we learn to live with COVID-19 and manage infection risks. A recent survey, carried out on our behalf, indicates that over 75% of people feel that the grief impact of the pandemic on the nation will be long-lasting. For bereaved individuals, planning funerals of loved ones, honouring that person and receiving the support of their extended family and friends makes for a good impact – we would be keen to minimise any negative impacts over time. Funerals by their nature are made up of both indoor and outdoor elements.
    [Show full text]
  • 1 National Public Health Emergency Team – COVID-19
    National Public Health Emergency Team – COVID-19 Meeting Note – Standing meeting Date and Time Thursday 25th February 2021, (Meeting 78) at 10:00am Location Department of Health, Miesian Plaza, Dublin 2 Chair Dr Ronan Glynn, Deputy Chief Medical Officer, DOH Dr Kevin Kelleher, Assistant National Director, Public Health, HSE Prof Philip Nolan, President, National University of Ireland, Maynooth and Chair of the Irish Epidemiological Modelling Advisory Group (IEMAG) Dr Cillian de Gascun, Laboratory Director, NVRL and Expert Advisory Group (EAG) Chair Dr Máirín Ryan, Deputy Chief Executive and Director of HTA, HIQA Dr John Cuddihy, Interim Director, HSE HPSC Prof Colm Bergin, Consultant in Infectious Diseases, St James’s Hospital Dr Siobhán Ní Bhriain, Lead for Integrated Care, HSE Dr Eibhlín Connolly, Deputy Chief Medical Officer, DOH Dr Mary Favier, Immediate past president of the ICGP, Covid-19 advisor Dr Michael Power, Consultant in Anaesthetics / Intensive Care Medicine, Beaumont Hospital Ms Rachel Kenna, Chief Nursing Officer, DOH Ms Tracey Conroy, Assistant Secretary, Acute Hospitals Policy Division, DOH Dr Lorraine Doherty, National Clinical Director Health Protection, HSE Dr Colette Bonner, Deputy Chief Medical Officer, DOH Ms Yvonne O’Neill, National Director, Community Operations, HSE Members via Mr Phelim Quinn, Chief Executive Officer, HIQA videoconference1 Dr Darina O’Flanagan, Special Advisor to the NPHET Mr Fergal Goodman, Assistant Secretary, Primary Care Division, DOH Dr Breda Smyth, Public Health Specialist, HSE Dr Kathleen
    [Show full text]
  • Mr. Paul Reid, Chief Executive Officer & Chair HSE National Crisis
    Mr. Paul Reid, Chief Executive Officer & Chair HSE National Crisis Management Team (NCMT), Health Services Executive, Dr Steevens’ Hospital, Dublin 8, D08 W2A8 18th January 2021 Via email to: [email protected] Dear Paul, Following the recent meeting of the COVID-19 National Public Health Emergency Team (NPHET), I wish to bring to your attention, as Chair of the HSE NCMT, the following decision of the NPHET which is now required to be actioned by the HSE and Health Protection Surveillance Centre (HPSC): • The NPHET endorsed the proposals for testing of close contacts as set out within “Review of duration of restriction of movements for individuals exposed, or potentially exposed, to Covid-19 (via close contact with a confirmed case only)”, to include: o The recommencement of testing of close contacts amongst the general public at day 5, as soon as swabbing, testing and contact tracing capacity can facilitate this development; o Close contacts of any positive case who has travelled from Great Britain, South Africa or Brazil should continue to be requested to self-isolate and get a test at day 5; o The urgent implementation of day 5 and day 10 testing for HCWs designated as close contacts, with exit from restricted movements if the Day 10 test is reported as ‘not detected’ I would like to take this opportunity to thank you and the wider team across the HSE for your ongoing support and work across the health and social care services as we move through the COVID-19 National Public Health Emergency. Officials from this Department have been and continue to be available to work with relevant HSE staff.
    [Show full text]
  • Interim Report on Testing and Tracing Special Committee on Covid-19 Response August 2020
    Tuarascáil Eatramhach maidir le Tástáil agus Rianú An Coiste Speisialta um Fhreagra ar Covid-19 Lúnasa 2020 Interim Report on Testing and Tracing Special Committee on Covid-19 Response August 2020 SCCR003 Interim Report on Testing and Tracing – August 2020 1 Tithe an Oireachtais An Coiste Speisialta um Fhreagra ar Covid-19 Tuarascáil Eatramhach maidir le Tástáil agus Rianú Lúnasa 2020 Houses of the Oireachtas Special Committee on Covid-19 Response Interim Report on Testing and Tracing August 2020 33 SCCR 003 Interim Report on Testing and Tracing – August 2020 Tracing and Testing Interim Report on Tuarascáil Eatramhach maidir le Tástáil agus Rianú – Lúnasa 2020 TABLE OF CONTENTS CHAIRMAN’S FOREWORD Contents I welcome the publication today of the Special Committee’s TABLE OF CONTENTS ............................................................................................................................... 2 Inteim epot on esting and acing CHAIRMAN’S FOREWORD .......................................................................................................................3 s the report outlines a obust system of testing and contact SUMMARY OF RECOMMENDATIONS ...................................................................................................... 6 tacing is the cental to allowin the phased eopening of Section 1: The importance of testing and tracing ............................................................................... 6 commecial and social activity, the maoity of which wee closed 2 Section 2: Detailed test
    [Show full text]
  • 1 National Public Health Emergency Team – COVID-19 Meeting Note
    National Public Health Emergency Team – COVID-19 Meeting Note Date and Time Sunday 4th October 2020, (Meeting 57) at 12:00pm Location Department of Health, Miesian Plaza, Dublin 2 Chair Dr Tony Holohan, Chief Medical Officer, DOH Dr Ronan Glynn, Deputy Chief Medical Officer, DOH Dr Kevin Kelleher, Assistant National Director, Public Health, HSE Prof Philip Nolan, President, National University of Ireland, Maynooth and Chair of the Irish Epidemiological Modelling Advisory Group (IEMAG) Dr Cillian de Gascun, Laboratory Director, NVRL and Expert Advisory Group (EAG) Chair Dr Máirín Ryan, Deputy Chief Executive and Director of HTA, HIQA Dr John Cuddihy, Interim Director, HSE HPSC Prof Colm Bergin, Consultant in Infectious Diseases, St James’s Hospital Dr Michael Power, Consultant in Anaesthetics / Intensive Care Medicine, Beaumont Hospital Dr Eibhlín Connolly, Deputy Chief Medical Officer, DOH Dr Mary Favier, Immediate past president of the ICGP, Covid-19 advisor Ms Tracey Conroy, Assistant Secretary, Acute Hospitals Policy Division, DOH Dr Siobhán O’Sullivan, Chief Bioethics Officer, DOH Dr Colette Bonner, Deputy Chief Medical Officer, DOH Mr Colm Desmond, Assistant Secretary, Corporate Legislation, Mental Health, Drugs Policy and Food Safety Division, DOH Members via Mr Phelim Quinn, Chief Executive Officer, HIQA videoconference Dr Darina O’Flanagan, Special Advisor to the NPHET Mr Fergal Goodman, Assistant Secretary, Primary Care Division, DOH Dr Breda Smyth, Public Health Specialist, HSE Mr Tom McGuinness, Assistant National Director
    [Show full text]
  • Face-Masks and the Limits of “Evidence-Based” Health Policy Dr
    Face-masks and the limits of “evidence-based” health policy Dr. Louise Caffrey argues that there is good enough evidence to support making face coverings compulsory, if you look beyond what’s strictly medical During the Covid-19 pandemic the Health Information and Quality Authority (HIQA) has been advising the Clinical Expert Advisory Group in supporting the National Public Health Emergency Team. Most recently, HIQA reviewed the evidence on the use of face covering to prevent people from transmitting the Covid-19 virus. Current policy is to only recommend the public wear face coverings rather than making them compulsory on, for example, public transport, in shops and in services. Particularly as we move out of lockdown, whether or not to mandate face coverings is a key question since we now know that the virus is spread, not just through coughing or sneezing, but also by speaking. People are contagious for days before they display symptoms and some people who are contagious never display symptoms. For this reason there is a need to stop people who have no idea they are sick giving the virus to others, for example, when they go to the supermarket or use public transport or indeed if they work in a shop or prepare food for the public. The government’s decision not to make face coverings in enclosed public spaces compulsory is highly controversial because face coverings are most effective at stopping people transmitting the virus. Face coverings are much less effective at stopping people who wear them from getting the virus. So for face coverings to be most effective, and for those wearing them to be well protected, they need to be worn by most people.
    [Show full text]
  • APRIL – JUNE 2020 Date Received Our Ref. 2020 Summary of Request
    APRIL – JUNE 2020 Date Our Summary of Request Category Decision Decision Received Ref. of Date Made 2020 Requester 30/06/2020 222 Records which document spend on mental health care via private services outside Business 30/09/2020 Part Granted the HSE i) within Ireland & ii) outside Ireland from 1 Jan 2018 to 31 May 2020. Interest Group 24/06/2020 221 Correspondence between the Department and DPER/DEASP on any review of Journalist 21/07/2020 Refused enhanced illness benefit in relation to covid-19 and possible consequences for the private healthcare worker workforce 24/06/2020 220 Letters and emails (including attachments) between CMO Tony Holohan and HSE Journalist 22/07/2020 Granted Chief Clinical Officer Colm Henry from April 1 to April 25, 2020. 24/06/2020 219 Representations to the Minister for Health, and the Minister's replies, in relation to Journalist 21/07/2020 Part Granted the Children & Family Relationships Act (2015), during the period Feb 1, 2014 to April 6, 2015 and the period Feb 1, 2019 to Feb 29, 2020 24/06/2020 218 Submissions made to the Department of Health in relation to the Assisted Human Journalist 31/07/2020 Part Granted Reproduction legislation during the period January 1, 2017 to January 31, 2020, 24/06/2020 217 Costs of production and distribution of both the Irish & English language Covid-19 Journalist 10/07/2020 Part Granted public information booklet + correspondences re; the initial Covid-19 public information booklet not being bilingual. 24/06/2020 216 Breakdown of details and costs on radio/television advertisements, social media Business 10/07/2020 Refused posts and adverts produced in English and Irish re; Covid-19 information.
    [Show full text]
  • Dáil Éireann
    Vol. 762 Tuesday, No. 3 24 April 2012 DÍOSPÓIREACHTAÍ PARLAIMINTE PARLIAMENTARY DEBATES DÁIL ÉIREANN TUAIRISC OIFIGIÚIL—Neamhcheartaithe (OFFICIAL REPORT—Unrevised) Dé Máirt, 24 Aibreán 2012. Ceisteanna — Questions Minister for Public Expenditure and Reform Priority Questions …………………………… 277 Other Questions …………………………… 286 Leaders’ Questions ……………………………… 296 Topical Issue Matters ……………………………… 304 Ceisteanna — Questions (resumed) Other Questions (resumed) The Taoiseach …………………………… 305 Estimates for Public Services 2012: Messages from Select Committees …………… 319 Order of Business ……………………………… 319 Ministerial Rota for Parliamentary Questions: Motion ………………… 326 Topical Issue Debate Pension Provisions …………………………… 327 Nursing Home Repayment Scheme ……………………… 329 Departmental Reports …………………………… 331 Garda Stations ……………………………… 333 Social Welfare and Pensions Bill 2012: Second Stage (resumed)……………………………336 Motion to Instruct Committee ………………………… 344 Private Members’ Business Motorist Emergency Relief Bill 2012: Second Stage ………………… 357 Questions: Written Answers …………………………… 379 DÁIL ÉIREANN ———— Dé Máirt, 24 Aibreán 2012. Tuesday, 24 April 2012. ———— Chuaigh an Ceann Comhairle i gceannas ar 2.00 p.m. ———— Paidir. Prayer. ———— Ceisteanna — Questions Priority Questions ———— Sale of State Assets 107. Deputy Sean Fleming asked the Minister for Public Expenditure and Reform if he will ensure that the sale of State assets will not include the disposal of any assets of a company involved in the provision of water supply to households throughout the country; and if he will make a statement on the matter. [20542/12] Minister for Public Expenditure and Reform (Deputy Brendan Howlin): As the House will be aware, the Government decided last week that the new Irish water utility is to be an indepen- dent State-owned subsidiary of Bord Gáis Éireann. The new water utility is not and will not be included in the Government’s programme of State asset disposals.
    [Show full text]